Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9876
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPandor, Aditi Kumari G.-
dc.date.accessioned2021-08-05T08:00:42Z-
dc.date.available2021-08-05T08:00:42Z-
dc.date.issued2021-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9876-
dc.description.abstractThe NP-HPLC method was developed and validated for the simultaneous determination of combination Abiraterone acetate and Prednisone and its stability indicating profile.Separation was achieved on T a r g e t s il l C 1 8 , ( 4 . 6 mm x 1 2 5 mm o f 3 μ m) column by using a mobile phase A consisted of water and glacial acetic acid in the ratio of (1000:1ml) %v/v and mobile phase B acetonitrile (500ml) with gradient program at a flow rate of 1.8ml/min. The detection wavelength was carried out by UV detector at 248nm. The Retention time was found to be 1.12 min and 9.53 min for Prednisone and Abiraterone acetate. The Abiraterone acetate and Prednisone over linearity in the range of 75% to 125% and recovery were found to be 95.2% and 96.7%. The Abiraterone acetate and Prednisone was subjected to stress condition of acid hydrolysis, alkali hydrolysis, peroxide oxidation, thermal degradation and UV degradation. It is stable in acid, peroxide and UV degradation. Drug was found to be degrading in alkaline and thermal degradation. The mass balance was found from 90% to 110%, thus proving the stability-indicating power of the method. The developed method was validated system suitability, linearity, accuracy and precision .Results of each parameter meet with its acceptance criteria. Hence the method will be useful for routine assay analysis.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00662;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Analysisen_US
dc.subject19MPHen_US
dc.subject19MPH301en_US
dc.subjectPDR00662en_US
dc.titleAnalytical Method Development and Validation of Stability Indicating Assay of Abiraterone Acetate and Prednisone by HPLC methoden_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00662_19MPH301.pdfPDR006624.38 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.